EPL Ltd Q4 FY2023 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/j1xbmfyk9zwf592rgh8rc8gn.pdf

Key Takeaways


Brazil Greenfield: From Promise to Production

Kripalu: "whatever we plan, whatever we have been talking about for the last 3, 4 quarters in Brazil is now a reality and will happen. And there are no surprises, no misses, no change in our position on Brazil. So the confidence on what Brazil will achieve remains."

Sustainable Tubes: The Competitive Moat

Kripalu: "I could make a sustainable tube using less plastic. I could make a sustainable tube that has better barrier properties for less plastic and less thickness compared to some other suppliers. So the customers' product may be unstable in somebody else's tube, but the product will be stable in our tube."
Kripalu: "Now price is a choice. That's a management choice. Now, I can charge a premium and make it difficult for people to convert, or I can say almost parity pricing, but you give me more volume, more market share and let me grow my business disproportionately during this period."

Margin Recovery: The Climb from 15.1% to 17.2%


Oral Care & Personal Care: The Mix Shift


Geographic Outlook: Diverging Fortunes

RegionTrendCommentary
Americas▲ Strong (17.1%)One-off inventory charge hit margins this quarter; underlying demand intact.
Europe▲ Strong (19.9%)Unprecedented pricing taken to offset inflation; Western economy uncertainty is the watchpoint.
AMESA▲ Strong (15.5% CC)Egypt performance strong but reported growth impacted by Egyptian pound devaluation; India remains robust.
EAP▲ Recovering (8.6%)Bounced back after COVID restrictions lifted; China expected to improve further on low base and government stimulus.
Western economies▼ UncertainInflation and recessionary fears make demand less predictable, per management.
Kripalu: "Inflation and recessionary fears, especially in the Western economy makes demand less predictable, okay."

Balance Sheet & Capital Allocation


Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growthDouble-digit revenue growthFY24
Sustainable tube mixDouble sustainable tubes to ~20% of totalFY24
Brazil ramp-upProduction commenced; ramp through FY24; margin-accretive on full-year basisFY24
Oral care growthSustain 8–10% growthOngoing
EAP recoveryDrive recovery based on expected China post-COVID revivalFY24
Capex (maintenance)Within depreciation amountFY24
Tax rate26–28%FY24
Margin trajectoryMargin improvement through mix and cost managementFY24

Key Metrics

MetricQ4 FY23
Revenue growth10.1%, broad-based across all regions
AMESA revenue growth7.6%, impacted by Egyptian pound devaluation; 15.5% at constant currency
Americas revenue growth17.1%
Europe revenue growth19.9%
EAP revenue growth8.6%, bounced back with lifting of COVID restrictions
EBITDA margin17.2%, excluding Brazil setup costs; improved 186 bps vs prior period
Net profit growth80.7%, partly enabled by tax credit pertaining to earlier years
Net debt to EBITDA0.60
Personal care and beyond share47% of total business
Sustainable tubes share~10% of total volumes, increased nearly 2.5x in FY23
Brazil greenfield total investment\$20 million approx
Government grants₹23.9 cr, duty benefit on import of machines
Tax rate guidance (FY24)26% to 28%
Capex guidance (FY24)Within depreciation amount, strategic capex like Brazil excluded
Egyptian pound devaluationEGP15 to EGP30 per \$1 over 9 months